- Institut de Recerca Biomèdica de Lleida (IRB-Lleida)
Institut d'investigació
![Foto de - Institut de Recerca Biomèdica de Lleida (IRB-Lleida)](/img/noimage.png)
![Foto de Centro de Investigación Biomédica en Red sobre Bioingeniería, Biomateriales y Nanomedicina](/img/noimage_org.png)
Centro de Investigación Biomédica en Red sobre Bioingeniería, Biomateriales y Nanomedicina
Madrid, EspañaPublicacións en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Bioingeniería, Biomateriales y Nanomedicina (31)
2024
-
Tetralol derivative NNC-55-0396 targets hypoxic cells in the glioblastoma microenvironment: an organ-on-chip approach
Cell death & disease, Vol. 15, Núm. 2, pp. 127
2023
-
Delivery Systems in Ocular Retinopathies: The Promising Future of Intravitreal Hydrogels as Sustained-Release Scaffolds
Pharmaceutics, Vol. 15, Núm. 5
-
Extracellular vesicles secreted by triple-negative breast cancer stem cells trigger premetastatic niche remodeling and metastatic growth in the lungs
International Journal of Cancer, Vol. 152, Núm. 10, pp. 2153-2165
2022
-
Colorectal cancer inhibition by BET inhibitor JQ1 is MYC-independent and not improved by nanoencapsulation
European Journal of Pharmaceutics and Biopharmaceutics, Vol. 171, pp. 39-49
2021
-
Identification of ZBTB18 as a novel colorectal tumor suppressor gene through genome-wide promoter hypermethylation analysis
Clinical Epigenetics, Vol. 13, Núm. 1
-
Polymeric micelles targeted against CD44v6 receptor increase niclosamide efficacy against colorectal cancer stem cells and reduce circulating tumor cells in vivo
Journal of Controlled Release, Vol. 331, pp. 198-212
2020
-
Development and validation of a sample entropy-based method to identify complex patient-ventilator interactions during mechanical ventilation
Scientific Reports, Vol. 10, Núm. 1
-
Intracellular delivery of anti-SMC2 antibodies against cancer stem cells
Pharmaceutics, Vol. 12, Núm. 2
-
Zileuton™ loaded in polymer micelles effectively reduce breast cancer circulating tumor cells and intratumoral cancer stem cells
Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 24
2019
-
Pivotal role of AKT2 during dynamic phenotypic change of breast cancer stem cells
Cancers, Vol. 11, Núm. 8
2018
-
AKT2 siRNA delivery with amphiphilic-based polymeric micelles show efficacy against cancer stem cells
Drug Delivery, Vol. 25, Núm. 1, pp. 961-972
-
Dynamism, sensitivity, and consequences of mesenchymal and stem-like phenotype of cancer cells
Stem Cells International, Vol. 2018
-
Efficient EFGR mediated siRNA delivery to breast cancer cells by Cetuximab functionalized Pluronic® F127/Gelatin
Chemical Engineering Journal, Vol. 340, pp. 81-93
-
Mechanisms of inactivation of the tumour suppressor gene RHOA in colorectal cancer
British Journal of Cancer, Vol. 118, Núm. 1, pp. 106-116
2017
-
Investigation of the role of tyrosine kinase receptor EPHA3 in colorectal cancer
Scientific Reports, Vol. 7
-
Loss of the EPH receptor B6 contributes to colorectal cancer metastasis
Scientific Reports, Vol. 7
2016
-
Cancer stem cells and personalized cancer nanomedicine
Nanomedicine, Vol. 11, Núm. 3, pp. 307-320
2015
-
Fluorescent CSC models evidence that targeted nanomedicines improve treatment sensitivity of breast and colon cancer stem cells
Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 11, Núm. 8, pp. 1883-1892
-
Highly expressed genes in rapidly proliferating tumor cells as new targets for colorectal cancer treatment
Clinical Cancer Research, Vol. 21, Núm. 16, pp. 3695-3704
2014
-
Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer
Cancer Research, Vol. 74, Núm. 12, pp. 3238-3247